Kestra Medical Technologies (NASDAQ:KMTS) CFO Sells 39,903 Shares of Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) CFO Vaseem Mahboob sold 39,903 shares of Kestra Medical Technologies stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $30.48, for a total transaction of $1,216,243.44. Following the sale, the chief financial officer owned 60,609 shares of the company’s stock, valued at $1,847,362.32. The trade was a 39.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Vaseem Mahboob also recently made the following trade(s):

• On Tuesday, October 27th, Vaseem Mahboob sold 34,809 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $30.04, for a total value of $1,045,662.36.
• On Thursday, October 29th, Vaseem Mahboob sold 4,788 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $30.60, for a total value of $146,512.80.
• On Friday, August 7th, Vaseem Mahboob sold 26,287 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $25.88, for a total value of $680,307.56.
• On Tuesday, August 4th, Vaseem Mahboob sold 6,995 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $24.68, for a total transaction of $172,636.60.
• On Monday, August 3rd, Vaseem Mahboob sold 5,391 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.80, for a total value of $128,305.80.
• On Friday, July 31st, Vaseem Mahboob sold 8,817 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.61, for a total transaction of $199,352.37.

Kestra Medical Technologies Stock Up 2.5%

Shares of NASDAQ KMTS traded up $0.74 during mid-day trading on Thursday, reaching $30.61. The company had a trading volume of 470,598 shares, compared to its average volume of 351,886. Kestra Medical Technologies, Ltd. has a 52-week low of $17.34 and a 52-week high of $31.04. The company has a current ratio of 4.69, a quick ratio of 4.69 and a debt-to-equity ratio of 0.33. The stock has a market cap of $1.82 billion, a P/E ratio of -11.46 and a beta of 0.51. The firm has a 50 day simple moving average of $26.59 and a two-hundred day simple moving average of $23.76.

Kestra Medical Technologies (NASDAQ:KMTS) last posted its quarterly earnings data on Monday, September 14th. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.14). Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. The firm had revenue of $30.97 million during the quarter. Sell-side analysts predict that Kestra Medical Technologies, Ltd. will post -2.45 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in KMTS. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Kestra Medical Technologies in the third quarter valued at about $353,000. Sterling Capital Management LLC boosted its position in shares of Kestra Medical Technologies by 834.0% in the third quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock worth $25,000 after acquiring an additional 784 shares during the last quarter. Corient Private Wealth LP grew its stake in shares of Kestra Medical Technologies by 284.2% during the 2nd quarter. Corient Private Wealth LP now owns 60,614 shares of the company’s stock valued at $1,542,000 after buying an additional 44,839 shares during the period. California State Teachers Retirement System raised its holdings in shares of Kestra Medical Technologies by 39.2% in the 1st quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock worth $555,000 after purchasing an additional 7,844 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its position in Kestra Medical Technologies by 6.6% during the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock valued at $1,844,000 after buying an additional 5,731 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on KMTS. Evercore started coverage on shares of Kestra Medical Technologies in a research note on Tuesday, October 20th. They set an “outperform” rating and a $34.00 price target on the stock. Wall Street Zen downgraded shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Saturday, September 12th. Weiss Ratings upgraded shares of Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, September 16th. Wolfe Research set a $30.00 target price on shares of Kestra Medical Technologies in a report on Wednesday, July 15th. Finally, Piper Sandler reiterated an “overweight” rating on shares of Kestra Medical Technologies in a research report on Tuesday, September 15th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Kestra Medical Technologies currently has an average rating of “Moderate Buy” and an average price target of $29.00.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.